Articles by RJ Palermo - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by RJ Palermo

INTERPHEX 2014: New Partners, New Programs

Conference sessions from PDA and PharmTech expand educational opportunities at INTERPHEX 2014.
Mar 2, 2014

Conference sessions from PDA and PharmTech expand educational opportunities at INTERPHEX 2014.

Critical Challenges Require Core Values

Industry has changed, but its basic tenets have not. INTERPHEX's RJ Palermo discusses a 7-step process to keep pharma moving forward.
Mar 2, 2009

Industry has changed, but its basic tenets have not. INTERPHEX's RJ Palermo discusses a 7-step process to keep pharma moving forward.

Guest Editorial: Interphex Focuses on Evolution of the Life Sciences

Show blasts off this month in Philadelphia with more suppliers, new trends, and real-world solutions
Mar 2, 2008

Show blasts off this month in Philadelphia with more suppliers, new trends, and real-world solutions.

Life-Science Biotech Growth Strategies: Cultivation and Regulation In Today's Global Marketplace

To effectively grow in the biotech industry, companies must develop multiphase plans that focus on regulation and efficiency.
Apr 2, 2007

To effectively grow in the biotech industry, companies must develop multiphase plans that focus on regulation and efficiency.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here